Genetics Meets Metabolism: Decoding Their Role in Idiopathic Scoliosis

Area of Science:

• Genetics and Developmental Biology
• Biochemistry
• Orthopedics

Background:

• Adolescent Idiopathic Scoliosis (AIS) is increasingly viewed as a multisystem disorder.
• Genetic susceptibility, metabolic dysregulation, and impaired mechanobiological signaling contribute to AIS pathogenesis.
• Defects in ciliary genes and disrupted ciliary signaling are implicated in altered spinal growth.

Purpose of the Study:

• To explore the integrated pathways contributing to Adolescent Idiopathic Scoliosis (AIS).
• To understand how genetic, metabolic, and mechanobiological factors interact in AIS.
• To identify potential opportunities for biomarker discovery and improved understanding of AIS.

Main Methods:

• Review of recent genomic studies on ciliary genes in AIS.
• Analysis of metabolic disturbances (pubertal hormones, oxidative stress, IGF-1) in relation to bone remodeling.
• Investigation of epigenetic regulators (microRNAs) and endocrine factors (melatonin) in skeletal development.
• Examination of primary cilia-dependent mechanotransduction pathways.

Main Results:

• Genomic studies reveal defects in ciliary genes, suggesting disrupted ciliary structure and signaling in AIS.
• Metabolic disturbances like altered IGF-1 activity and oxidative stress can exacerbate genetic vulnerabilities.
• Epigenetic and endocrine factors integrate metabolic cues with gene expression relevant to skeletal development.
• Converging pathways disrupt primary cilia-dependent mechanotransduction, leading to asymmetric vertebral growth.

Conclusions:

• AIS is a systemic condition resulting from the interplay of genetic, metabolic, and mechanobiological factors.
• Disrupted primary cilia-dependent mechanotransduction is a key mechanism in AIS pathogenesis.
• This integrated framework opens new avenues for biomarker discovery and therapeutic strategies for AIS.